CoChat
Sign Up
Cited by 576

The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.

EASL Clinical Practice Guidelines on the prevention, diagnosis and treatment of gallstones

·2016·Journal of Hepatology
DOI 10.1016/j.jhep.2016.03.005
Open this paper in CoChat — free account

Overview

Integrity signals

Registry

Crossref · 10.1016/j.jhep.2016.03.005

Cites

15 of 15 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Flagged first, then by citations

Show all 15 references

Research works printed but not linked: 647

  1. Farthing, 2014, Survey of digestive health across Europe: final report. Part 1: The burden of gastrointestinal diseases and the organisation and delivery of gastroenterology services across Europe, UEG J, 2, 539, 10.1177/2050640614554154 · DOI
  2. Atkins, 2004, Grading quality of evidence and strength of recommendations, BMJ, 328, 1490, 10.1136/bmj.328.7454.1490 · DOI · Paper page
  3. Portincasa, 2006, Cholesterol gallstone disease, Lancet, 368, 230, 10.1016/S0140-6736(06)69044-2 · DOI · Paper page
  4. Neoptolemos, 1986, Chemical treatment of stones in the biliary tree, Br J Surg, 73, 515, 10.1002/bjs.1800730703 · DOI
  5. Hofmann, 1993, Primary and secondary prevention of gallstone disease: implications for patient management and research priorities, Am J Surg, 165, 541, 10.1016/S0002-9610(05)80958-4 · DOI
  6. Krawczyk, 2011, Dissecting the genetic heterogeneity of gallbladder stone formation, Semin Liver Dis, 31, 157, 10.1055/s-0031-1276645 · DOI
  7. Biddinger, 2008, Hepatic insulin resistance directly promotes formation of cholesterol gallstones, Nat Med, 14, 778, 10.1038/nm1785 · DOI
  8. Grundy, 2004, Cholesterol gallstones: a fellow traveler with metabolic syndrome?, Am J Clin Nutr, 80, 1, 10.1093/ajcn/80.1.1 · DOI
  9. Chen, 2012, Metabolic syndrome and gallstone disease, World J Gastroenterol, 18, 4215, 10.3748/wjg.v18.i31.4215 · DOI
  10. Ruhl, 2000, Association of diabetes, serum insulin, and C-peptide with gallbladder disease, Hepatology, 31, 299, 10.1002/hep.510310206 · DOI
  11. Haffner, 1990, Increased prevalence of clinical gallbladder disease in subjects with non-insulin-dependent diabetes mellitus, Am J Epidemiol, 132, 327, 10.1093/oxfordjournals.aje.a115662 · DOI
  12. Misciagna, 2000, Insulin and gall stones: a population case control study in southern Italy, Gut, 47, 144, 10.1136/gut.47.1.144 · DOI
  13. Friedman, 1966, The epidemiology of gallbladder disease: observations in the Framingham Study, J Chronic Dis, 19, 273, 10.1016/0021-9681(66)90132-9 · DOI
  14. 1988, The epidemiology of gallstone disease in Rome Italy. Part I. Prevalence data in men. The Rome Group for Epidemiology and Prevention of Cholelithiasis (GREPCO), Hepatology, 8, 904, 10.1002/hep.1840080433 · DOI
  15. Völzke, 2005, Independent risk factors for gallstone formation in a region with high cholelithiasis prevalence, Digestion, 71, 97, 10.1159/000084525 · DOI · Paper page
  16. Maclure, 1989, Weight, diet, and the risk of symptomatic gallstones in middle-aged women, N Engl J Med, 321, 563, 10.1056/NEJM198908313210902 · DOI · Paper page
  17. Tsai, 2006, Central adiposity, regional fat distribution, and the risk of cholecystectomy in women, Gut, 55, 708, 10.1136/gut.2005.076133 · DOI · Paper page
  18. Willett, 1999, Guidelines for healthy weight, N Engl J Med, 341, 427, 10.1056/NEJM199908053410607 · DOI
  19. Scragg, 1984, Diet, alcohol, and relative weight in gall stone disease: a case-control study, BMJ, 288, 1113, 10.1136/bmj.288.6424.1113 · DOI
  20. Jorgensen, 1987, Prevalence of gallstones in a Danish population, Am J Epidemiol, 126, 912, 10.1093/oxfordjournals.aje.a114728 · DOI
  21. Stampfer, 1992, Risk of symptomatic gallstones in women with severe obesity, Am J Clin Nutr, 55, 652, 10.1093/ajcn/55.3.652 · DOI
  22. Amaral, 1985, Gallbladder disease in the morbidly obese, Am J Surg, 149, 551, 10.1016/S0002-9610(85)80055-6 · DOI · Paper page
  23. Scragg, 1984, Plasma lipids and insulin in gall stone disease: a case-control study, BMJ, 289, 521, 10.1136/bmj.289.6444.521 · DOI
  24. Stinton, 2010, Epidemiology of gallstones, Gastroenterol Clin North Am, 39, 157, 10.1016/j.gtc.2010.02.003 · DOI
  25. Stender, 2013, Elevated body mass index as a causal risk factor for symptomatic gallstone disease: a mendelian randomization study, Hepatology, 58, 2133, 10.1002/hep.26563 · DOI · Paper page
  26. Banim, 2011, The aetiology of symptomatic gallstones quantification of the effects of obesity, alcohol and serum lipids on risk. Epidemiological and biomarker data from a UK prospective cohort study (EPIC-Norfolk), Eur J Gastroenterol Hepatol, 23, 733, 10.1097/MEG.0b013e3283477cc9 · DOI
  27. Di Ciaula, 2012, Gallbladder and gastric motility in obese newborns, pre-adolescents and adults, J Gastroenterol Hepatol, 27, 1298, 10.1111/j.1440-1746.2012.07149.x · DOI · Paper page
  28. Vezina, 1990, Increased volume and decreased emptying of the gallbladder in large (morbidly obese, tall normal, and muscular normal) people, Gastroenterology, 98, 1000, 10.1016/0016-5085(90)90025-V · DOI
  29. Portincasa, 2008, Coordinate regulation of gallbladder motor function in the gut-liver axis, Hepatology, 47, 2112, 10.1002/hep.22204 · DOI
  30. Portincasa, 1995, Effects of cholestyramine on gallbladder and gastric emptying in obese and lean subjects, Eur J Clin Invest, 25, 746, 10.1111/j.1365-2362.1995.tb01953.x · DOI
  31. Leitzmann, 1999, Recreational physical activity and the risk of cholecystectomy in women, N Engl J Med, 341, 777, 10.1056/NEJM199909093411101 · DOI · Paper page
  32. Boland, 2002, Atherosclerosis Risk in Communities Study I. Hyperinsulinemia, dyslipidemia, and obesity as risk factors for hospitalized gallbladder disease. A prospective study, Ann Epidemiol, 12, 131, 10.1016/S1047-2797(01)00260-5 · DOI
  33. Festi, 2008, Incidence of gallstone disease in Italy: results from a multicenter, population-based Italian study (the MICOL project), World J Gastroenterol, 14, 5282, 10.3748/wjg.14.5282 · DOI
  34. Thijs, 1990, Serum lipids and gallstones: a case-control study, Gastroenterology, 99, 843, 10.1016/0016-5085(90)90978-A · DOI
  35. Marks, 1984, Lack of correlation between serum lipoproteins and biliary cholesterol saturation in patients with gallstones, Dig Dis Sci, 29, 1118, 10.1007/BF01317086 · DOI
  36. Petitti, 1981, Association of a history of gallbladder disease with a reduced concentration of high-density-lipoprotein cholesterol, N Engl J Med, 304, 1396, 10.1056/NEJM198106043042305 · DOI
  37. Attili, 1997, Factors associated with gallstone disease in the MICOL experience. Multicenter Italian Study on Epidemiology of Cholelithiasis, Hepatology, 26, 809, 10.1002/hep.510260401 · DOI
  38. Jorgensen, 1989, Gallstones and plasma lipids in a Danish population, Scand J Gastroenterol, 24, 916, 10.3109/00365528909089235 · DOI
  39. Weikert, 2010, Presence of gallstones or kidney stones and risk of type 2 diabetes, Am J Epidemiol, 171, 447, 10.1093/aje/kwp411 · DOI
  40. Leitzmann, 1998, The relation of physical activity to risk for symptomatic gallstone disease in men, Ann Intern Med, 128, 417, 10.7326/0003-4819-128-6-199803150-00001 · DOI · Paper page
  41. Misciagna, 1999, Diet, physical activity, and gallstones – A population-based, case-control study in southern Italy, Am J Clin Nutr, 69, 120, 10.1093/ajcn/69.1.120 · DOI
  42. Walcher, 2010, The effect of alcohol, tobacco and caffeine consumption and vegetarian diet on gallstone prevalence, Eur J Gastroenterol Hepatol, 22, 1345, 10.1097/MEG.0b013e32833efdb2 · DOI
  43. Ortega, 1997, Differences in diet and food habits between patients with gallstones and controls, J Am Coll Nutr, 16, 88, 10.1080/07315724.1997.10718655 · DOI · Paper page
  44. Kriska, 2007, Physical activity and gallbladder disease determined by ultrasonography, Med Sci Sports Exerc, 39, 1927, 10.1249/mss.0b013e3181484d0e · DOI · Paper page
  45. Storti, 2005, Physical activity and decreased risk of clinical gallstone disease among post-menopausal women, Prev Med, 41, 772, 10.1016/j.ypmed.2005.04.002 · DOI · Paper page
  46. Kato, 1992, Factors associated with levels of physical activity at work and during leisure time, Nihon Koshu Eisei Zasshi, 39, 822
  47. Banim, 2010, Physical activity reduces the risk of symptomatic gallstones: a prospective cohort study, Eur J Gastroenterol Hepatol, 22, 983, 10.1097/MEG.0b013e32833732c3 · DOI
  48. Chait, 1979, Low-density lipoprotein receptor activity in cultured human skin fibroblasts. Mechanism of insulin-induced stimulation, J Clin Invest, 64, 1309, 10.1172/JCI109587 · DOI
  49. Nepokroeff, 1974, Regulation of the diurnal rhythm of rat liver beta-hydroxy-beta-methylglutaryl coenzmye A reductase activity by insulin, glucagon, cyclic AMP and hydrocortisone, Arch Biochem Biophys, 160, 387, 10.1016/0003-9861(74)90412-3 · DOI
  50. Subbiah, 1984, Cholesterol 7 alpha-hydroxylase of rat liver: an insulin sensitive enzyme, Biochem Biophys Res Commun, 124, 896, 10.1016/0006-291X(84)91042-8 · DOI
  51. Kirwan, 1993, Endurance exercise training reduces glucose-stimulated insulin levels in 60- to 70-year-old men and women, J Gerontol, 48, M84, 10.1093/geronj/48.3.M84 · DOI
  52. Seals, 1984, Effects of endurance training on glucose tolerance and plasma lipid levels in older men and women, JAMA, 252, 645, 10.1001/jama.1984.03350050033022 · DOI
  53. Tran, 1983, The effects of exercise on blood lipids and lipoproteins: a meta-analysis of studies, Med Sci Sports Exerc, 15, 393
  54. Mingrone, 1988, Free fatty acids: a stimulus for mucin hypersecretion in cholesterol gallstone biles, Biochim Biophys Acta, 958, 52, 10.1016/0005-2760(88)90245-7 · DOI
  55. Leon, 2001, Response of blood lipids to exercise training alone or combined with dietary intervention, Med Sci Sports Exerc, 33, S502, 10.1097/00005768-200106001-00021 · DOI · Paper page
  56. Baker, 1986, Alterations in lipid and protein profiles of plasma lipoproteins in middle-aged men consequent to an aerobic exercise program, Metabolism, 35, 1037, 10.1016/0026-0495(86)90040-5 · DOI
  57. Gupta, 1993, Increased reverse cholesterol transport in athletes, Metabolism, 42, 684, 10.1016/0026-0495(93)90233-E · DOI
  58. Halloran, 1978, Evidence for high-density lipoprotein-free cholesterol as the primary precursor for bile-acid synthesis in man, Surgery, 84, 1
  59. Koffler, 1992, Strength training accelerates gastrointestinal transit in middle-aged and older men, Med Sci Sports Exerc, 24, 415, 10.1249/00005768-199204000-00004 · DOI
  60. Philipp, 1992, Cholecystokinin, gastrin and stress hormone responses in marathon runners, Peptides, 13, 125, 10.1016/0196-9781(92)90150-2 · DOI
  61. Tsunoda, 2004, Prevalence of cholesterol gallstones positively correlates with per capita daily calorie intake, Hepatogastroenterology, 51, 1271
  62. Mendez-Sanchez, 2007, Role of diet in cholesterol gallstone formation, Clin Chim Acta, 376, 1, 10.1016/j.cca.2006.08.036 · DOI
  63. Tsai, 2006, Fruit and vegetable consumption and risk of cholecystectomy in women, Am J Med, 119, 760, 10.1016/j.amjmed.2006.02.040 · DOI
  64. Key, 1999, Health benefits of a vegetarian diet, Proc Nutr Soc, 58, 271, 10.1017/S0029665199000373 · DOI
  65. Simon, 2000, Serum ascorbic acid and gallbladder disease prevalence among US adults: the Third National Health and Nutrition Examination Survey (NHANES III), Arch Intern Med, 160, 931, 10.1001/archinte.160.7.931 · DOI
  66. Biss, 1971, Some unique biologic characteristics of the Masai of East Africa, N Engl J Med, 284, 694, 10.1056/NEJM197104012841304 · DOI
  67. Kratzer, 1999, Prevalence of cholecystolithiasis in South Germany - an ultrasound study of 2,498 persons of a rural population, Z Gastroenterol, 37, 1157
  68. Kratzer, 1998, Gallstone prevalence in Germany: the Ulm Gallbladder Stone Study, Dig Dis Sci, 43, 1285, 10.1023/A:1018816109905 · DOI
  69. Pixley, 1988, Dietary factors in the aetiology of gall stones: a case control study, Gut, 29, 1511, 10.1136/gut.29.11.1511 · DOI
  70. Pixley, 1985, Effect of vegetarianism on development of gall stones in women, BMJ, 291, 11, 10.1136/bmj.291.6487.11 · DOI
  71. Nervi, 1989, Influence of legume intake on biliary lipids and cholesterol saturation in young Chilean men. Identification of a dietary risk factor for cholesterol gallstone formation in a highly prevalent area, Gastroenterology, 96, 825, 10.1016/S0016-5085(89)80083-6 · DOI
  72. Tsai, 2004, The effect of long-term intake of cis unsaturated fats on the risk for gallstone disease in men: a prospective cohort study, Ann Intern Med, 141, 514, 10.7326/0003-4819-141-7-200410050-00007 · DOI · Paper page
  73. Leitzmann, 2003, Alcohol consumption in relation to risk of cholecystectomy in women, Am J Clin Nutr, 78, 339, 10.1093/ajcn/78.2.339 · DOI
  74. Leitzmann, 1999, A prospective study of coffee consumption and the risk of symptomatic gallstone disease in men, JAMA, 281, 2106, 10.1001/jama.281.22.2106 · DOI
  75. Leitzmann, 2002, Coffee intake is associated with lower risk of symptomatic gallstone disease in women, Gastroenterology, 123, 1823, 10.1053/gast.2002.37054 · DOI
  76. La Vecchia, 1991, Risk factors for gallstone disease requiring surgery, Int J Epidemiol, 20, 209, 10.1093/ije/20.1.209 · DOI
  77. Jorgensen, 1989, Gall stones in a Danish population. Relation to weight, physical activity, smoking, coffee consumption, and diabetes mellitus, Gut, 30, 528, 10.1136/gut.30.4.528 · DOI
  78. Misciagna, 1996, Epidemiology of cholelithiasis in southern Italy. Part II: Risk factors, Eur J Gastroenterol Hepatol, 8, 585, 10.1097/00042737-199606000-00017 · DOI
  79. Ruhl, 2000, Association of coffee consumption with gallbladder disease, Am J Epidemiol, 152, 1034, 10.1093/aje/152.11.1034 · DOI
  80. Kratzer, 1997, Gallstone prevalence in relation to smoking, alcohol, coffee consumption, and nutrition. The Ulm Gallstone Study, Scand J Gastroenterol, 32, 953, 10.3109/00365529709011208 · DOI
  81. Basso, 1992, A descriptive study of pregnant women with gallstones. Relation to dietary and social habits, education, physical activity, height, and weight, Eur J Epidemiol, 8, 629, 10.1007/BF00145375 · DOI
  82. Ginter, 1973, Cholesterol: vitamin C controls its transformation to bile acids, Science, 179, 702, 10.1126/science.179.4074.702 · DOI
  83. Ginter, 1976, Chenodeoxycholic acid, gallstones and vitamin C, N Engl J Med, 295, 1260, 10.1056/NEJM197611252952218 · DOI
  84. Gustafsson, 1997, The effect of vitamin C in high doses on plasma and biliary lipid composition in patients with cholesterol gallstones: prolongation of the nucleation time, Eur J Clin Invest, 27, 387, 10.1046/j.1365-2362.1997.1240670.x · DOI
  85. Simon, 1998, Serum ascorbic acid and other correlates of gallbladder disease among US adults, Am J Public Health, 88, 1208, 10.2105/AJPH.88.8.1208 · DOI
  86. Simon, 1998, Ascorbic acid supplement use and the prevalence of gallbladder disease. Heart & Estrogen-Progestin Replacement Study (HERS) Research Group, J Clin Epidemiol, 51, 257, 10.1016/S0895-4356(97)80280-6 · DOI
  87. Walcher, 2009, Vitamin C supplement use may protect against gallstones: an observational study on a randomly selected population, BMC Gastroenterol, 9, 74, 10.1186/1471-230X-9-74 · DOI
  88. Mendez-Sanchez, 2001, Fish oil (n-3) polyunsaturated fatty acids beneficially affect biliary cholesterol nucleation time in obese women losing weight, J Nutr, 131, 2300, 10.1093/jn/131.9.2300 · DOI · Paper page
  89. Bodmer, 2009, Statin use and risk of gallstone disease followed by cholecystectomy, JAMA, 302, 2001, 10.1001/jama.2009.1601 · DOI
  90. Erichsen, 2011, Long-term statin use and the risk of gallstone disease: a population-based case-control study, Am J Epidemiol, 173, 162, 10.1093/aje/kwq361 · DOI
  91. Tsai, 2009, Statin use and the risk of cholecystectomy in women, Gastroenterology, 136, 1593, 10.1053/j.gastro.2009.01.042 · DOI
  92. Merzon, 2010, Statin administration and risk of cholecystectomy: a population-based case-control study, Expert Opin Drug Saf, 9, 539, 10.1517/14740338.2010.485190 · DOI
  93. Duane, 1994, Effects of lovastatin and dietary cholesterol on bile acid kinetics and bile lipid composition in healthy male subjects, J Lipid Res, 35, 501, 10.1016/S0022-2275(20)41201-5 · DOI
  94. Logan, 1990, Lovastatin added to ursodeoxycholic acid further reduces biliary cholesterol saturation, Gastroenterology, 98, 1572, 10.1016/0016-5085(90)91092-K · DOI
  95. Mitchell, 1991, Effects of lovastatin on biliary lipid secretion and bile acid metabolism in humans, J Lipid Res, 32, 71, 10.1016/S0022-2275(20)42245-X · DOI
  96. Glasinovic, 1996, Gallstone dissolution in an adult female population: trial with lovastatin therapy, Rev Med Chil, 124, 793
  97. Hoogerbrugge-vd Linden, 1990, Effect of pravastatin on biliary lipid composition and bile acid synthesis in familial hypercholesterolaemia, Gut, 31, 348, 10.1136/gut.31.3.348 · DOI
  98. Smit, 1995, Effects of simvastatin and cholestyramine on bile lipid composition and gall bladder motility in patients with hypercholesterolaemia, Gut, 37, 654, 10.1136/gut.37.5.654 · DOI
  99. Smit, 1992, Successful dissolution of cholesterol gallstone during treatment with pravastatin, Gastroenterology, 103, 1068, 10.1016/0016-5085(92)90045-Z · DOI
  100. Horiuchi, 1991, Effects of pravastatin (CS-514) on biliary lipid metabolism in patients with hyperlipidemia, Metabolism, 40, 226, 10.1016/0026-0495(91)90101-2 · DOI
  101. Sharma, 1997, Endoscopic management of acute calculous cholangitis, J Gastroenterol Hepatol, 12, 874, 10.1111/j.1440-1746.1997.tb00386.x · DOI
  102. Hillebrant, 2002, Effects of combined treatment with pravastatin and ursodeoxycholic acid on hepatic cholesterol metabolism, Eur J Clin Invest, 32, 528, 10.1046/j.1365-2362.2002.01015.x · DOI
  103. Duane, 1988, Simvastatin, a competitive inhibitor of HMG-CoA reductase, lowers cholesterol saturation index of gallbladder bile, Hepatology, 8, 1147, 10.1002/hep.1840080531 · DOI
  104. Chapman, 1998, Dissolution of gallstones with simvastatin, an HMG CoA reductase inhibitor, Dig Dis Sci, 43, 349, 10.1023/A:1018862507469 · DOI
  105. Allescher, 1996, Differentialtherapie der akuten und chronischen Cholangitis, Bay Internist, 16, 29
  106. Miettinen, 1998, Cholesterol metabolism and serum and biliary noncholesterol sterols in gallstone patients during simvastatin and ursodeoxycholic acid treatments, Hepatology, 27, 649, 10.1002/hep.510270302 · DOI
  107. Smith, 2000, Effects of simvastatin on hepatic cholesterol metabolism, bile lithogenicity and bile acid hydrophobicity in patients with gallstones, J Gastroenterol Hepatol, 15, 871, 10.1046/j.1440-1746.2000.02231.x · DOI
  108. Pauletzki, 1995, Gallstone recurrence after direct contact dissolution with methyl tert-butyl ether, Dig Dis Sci, 40, 1775, 10.1007/BF02212701 · DOI
  109. Mazzella, 1992, Effect of simvastatin, ursodeoxycholic acid and simvastatin plus ursodeoxycholic acid on biliary lipid secretion and cholic acid kinetics in nonfamilial hypercholesterolemia, Hepatology, 15, 1072, 10.1002/hep.1840150617 · DOI
  110. Porsch-Ozcurumez, 2001, Effects of fluvastatin on biliary lipids in subjects with an elevated cholesterol saturation index, Eur J Clin Pharmacol, 56, 873, 10.1007/s002280000254 · DOI
  111. Kan, 2014, Statin use and risk of gallstone disease: a meta-analysis, Hepatol Res
  112. Pulkkinen, 2014, Effect of statin use on outcome of symptomatic cholelithiasis: a case-control study, BMC Gastroenterol, 14, 119, 10.1186/1471-230X-14-119 · DOI
  113. Di Ciaula, 2014, Therapeutic reflections in cholesterol homeostasis and gallstone disease: a review, Curr Med Chem, 21, 1435, 10.2174/09298673113206660271 · DOI
  114. Lioudaki, 2011, Lipid lowering drugs and gallstones: a therapeutic option?, Curr Pharm Des, 17, 3622, 10.2174/138161211798220909 · DOI
  115. Wang, 2008, Effect of ezetimibe on the prevention and dissolution of cholesterol gallstones, Gastroenterology, 134, 2101, 10.1053/j.gastro.2008.03.011 · DOI
  116. Zuniga, 2008, Ezetimibe prevents cholesterol gallstone formation in mice, Liver Int, 28, 935, 10.1111/j.1478-3231.2008.01808.x · DOI
  117. Mathur, 2007, Ezetimibe ameliorates cholecystosteatosis, Surgery, 142, 228, 10.1016/j.surg.2007.04.007 · DOI
  118. de Bari, 2014, Ezetimibe prevents the formation of oestrogen-induced cholesterol gallstones in mice, Eur J Clin Invest, 44, 1159, 10.1111/eci.12350 · DOI
  119. Valasek, 2008, Inhibiting intestinal NPC1L1 activity prevents diet-induced increase in biliary cholesterol in Golden Syrian hamsters, Am J Physiol Gastrointest Liver Physiol, 295, G813, 10.1152/ajpgi.90372.2008 · DOI
  120. Stein, 2012, Effect of ezetimibe on the prevalence of cholelithiasis, World J Gastroenterol, 18, 5789, 10.3748/wjg.v18.i40.5789 · DOI
  121. Lauridsen, 2015, Genetic variation in the cholesterol transporter NPC1L1, ischaemic vascular disease, and gallstone disease, Eur Heart J, 36, 1601, 10.1093/eurheartj/ehv108 · DOI
  122. DiCiaula, 2010, Targets for current pharmacologic therapy in cholesterol gallstone disease, Gastroenterol Clin North Am, 39, 245, 10.1016/j.gtc.2010.02.005 · DOI
  123. Wang, 2013, Prevention of cholesterol gallstones by inhibiting hepatic biosynthesis and intestinal absorption of cholesterol, Eur J Clin Invest, 43, 413, 10.1111/eci.12058 · DOI
  124. Tsai, 2006, Weight cycling and risk of gallstone disease in men, Arch Intern Med, 166, 2369, 10.1001/archinte.166.21.2369 · DOI · Paper page
  125. Yang, 1992, Risk factors for gallstone formation during rapid loss of weight, Dig Dis Sci, 37, 912, 10.1007/BF01300390 · DOI · Paper page
  126. Portincasa, 2012, Intestinal absorption, hepatic synthesis, and biliary secretion of cholesterol: where are we for cholesterol gallstone formation?, Hepatology, 55, 1313, 10.1002/hep.25604 · DOI
  127. Weinsier, 1993, Gallstone formation and weight loss, Obes Res, 1, 51, 10.1002/j.1550-8528.1993.tb00008.x · DOI · Paper page
  128. Everhart, 1993, Contributions of obesity and weight loss to gallstone disease, Ann Intern Med, 119, 1029, 10.7326/0003-4819-119-10-199311150-00010 · DOI · Paper page
  129. Worobetz, 1993, The effect of ursodeoxycholic acid therapy on gallstone formation in the morbidly obese during rapid weight loss, Am J Gastroenterol, 88, 1705
  130. Syngal, 1999, Long-term weight patterns and risk for cholecystectomy in women, Ann Intern Med, 130, 471, 10.7326/0003-4819-130-6-199903160-00003 · DOI · Paper page
  131. Heshka, 1996, Obesity and risk of gallstone development on a 1200 kcal/d (5025 Kj/d) regular food diet, Int J Obes Relat Metab Disord, 20, 450
  132. Al-Jiffry, 2003, Changes in gallbladder motility and gallstone formation following laparoscopic gastric banding for morbid obestity, Can J Gastroenterol, 17, 169, 10.1155/2003/392719 · DOI
  133. Festi, 2015, Risk factors for gallstone formation during weight loss, Clin Gastroenterol Hepatol, 13, 613, 10.1016/j.cgh.2014.08.010 · DOI
  134. Tsai, 2005, Systematic review: an evaluation of major commercial weight loss programs in the United States, Ann Intern Med, 142, 56, 10.7326/0003-4819-142-1-200501040-00012 · DOI · Paper page
  135. Kamrath, 1992, Cholelithiasis in patients treated with a very-low-calorie diet, Am J Clin Nutr, 56, 255S, 10.1093/ajcn/56.1.255S · DOI · Paper page
  136. Liddle, 1989, Gallstone formation during weight-reduction dieting, Arch Intern Med, 149, 1750, 10.1001/archinte.1989.00390080036009 · DOI · Paper page
  137. Shiffman, 1995, Prophylaxis against gallstone formation with ursodeoxycholic acid in patients participating in a very-low-calorie diet program, Ann Intern Med, 122, 899, 10.7326/0003-4819-122-12-199506150-00002 · DOI · Paper page
  138. Broomfield, 1988, Effects of ursodeoxycholic acid and aspirin on the formation of lithogenic bile and gallstones during loss of weight, N Engl J Med, 319, 1567, 10.1056/NEJM198812153192403 · DOI · Paper page
  139. Williams, 1993, A double-blind placebo-controlled trial of ursodeoxycholic acid in the prevention of gallstones during weight loss after vertical banded gastroplasty, Obes Surg, 3, 257, 10.1381/096089293765559278 · DOI · Paper page
  140. Sugerman, 1995, A multicenter, placebo-controlled, randomized, double-blind, prospective trial of prophylactic ursodiol for the prevention of gallstone formation following gastric-bypass-induced rapid weight loss, Am J Surg, 169, 91, 10.1016/S0002-9610(99)80115-9 · DOI · Paper page
  141. Wudel, 2002, Prevention of gallstone formation in morbidly obese patients undergoing rapid weight loss: results of a randomized controlled pilot study, J Surg Res, 102, 50, 10.1006/jsre.2001.6322 · DOI · Paper page
  142. Festi, 1998, Gallbladder motility and gallstone formation in obese patients following very low calorie diets. Use it (fat) to lose it (well), Int J Obes Relat Metab Disord, 22, 592, 10.1038/sj.ijo.0800634 · DOI · Paper page
  143. Shiffman, 1991, Gallstone formation after rapid weight loss: a prospective study in patients undergoing gastric bypass surgery for treatment of morbid obesity, Am J Gastroenterol, 86, 1000
  144. Schmidt, 1988, The case for prophylactic cholecystectomy concomitant with gastric restriction for morbid obesity, Am Surg, 54, 269
  145. O’Brien, 2003, A rational approach to cholelithiasis in bariatric surgery: its application to the laparoscopically placed adjustable gastric band, Arch Surg, 138, 908, 10.1001/archsurg.138.8.908 · DOI · Paper page
  146. Villegas, 2004, Is routine cholecystectomy required during laparoscopic gastric bypass?, Obes Surg, 14, 206, 10.1381/096089204322857573 · DOI
  147. Li, 2009, Symptomatic gallstones after sleeve gastrectomy, Surg Endosc, 23, 2488, 10.1007/s00464-009-0422-6 · DOI
  148. D’Hondt, 2011, Prophylactic cholecystectomy, a mandatory step in morbidly obese patients undergoing laparoscopic Roux-en-Y gastric bypass?, J Gastrointest Surg, 15, 1532, 10.1007/s11605-011-1617-4 · DOI
  149. Moon, 2014, Comparison of cholecystectomy cases after Roux-en-Y gastric bypass, sleeve gastrectomy, and gastric banding, Surg Obes Relat Dis, 10, 64, 10.1016/j.soard.2013.04.019 · DOI
  150. Tsirline, 2014, How frequently and when do patients undergo cholecystectomy after bariatric surgery?, Surg Obes Relat Dis, 10, 313, 10.1016/j.soard.2013.10.011 · DOI · Paper page
  151. Uy, 2008, Ursodeoxycholic acid in the prevention of gallstone formation after bariatric surgery: a meta-analysis, Obes Surg, 18, 1532, 10.1007/s11695-008-9587-7 · DOI · Paper page
  152. Shoheiber, 1997, Estimation of the cost savings resulting from the use of ursodiol for the prevention of gallstones in obese patients undergoing rapid weight reduction, Int J Obes Relat Metab Disord, 21, 1038, 10.1038/sj.ijo.0800513 · DOI
  153. Stokes, 2015, Risk factors for gallstone formation during weight loss. Reply, Clin Gastroenterol Hepatol, 13, 614, 10.1016/j.cgh.2014.12.011 · DOI
  154. Adamek, 1994, Can aspirin prevent gallstone recurrence after successful extracorporeal shockwave lithotripsy?, Scand J Gastroenterol, 29, 355, 10.3109/00365529409094849 · DOI
  155. Papasavas, 2006, Routine gallbladder screening not necessary in patients undergoing laparoscopic Roux-en-Y gastric bypass, Surg Obes Relat Dis, 2, 41, 10.1016/j.soard.2005.10.006 · DOI
  156. Patel, 2009, Perioperative management of cholelithiasis in patients presenting for laparoscopic Roux-en-Y gastric bypass: have we reached a consensus?, Am Surg, 75, 470, 10.1177/000313480907500604 · DOI
  157. Kim, 2009, Safety and efficacy of simultaneous cholecystectomy at Roux-en-Y gastric bypass, Surg Obes Relat Dis, 5, 48, 10.1016/j.soard.2008.06.001 · DOI · Paper page
  158. Tucker, 2008, Is concomitant cholecystectomy necessary in obese patients undergoing laparoscopic gastric bypass surgery?, Surg Endosc, 22, 2450, 10.1007/s00464-008-9769-3 · DOI
  159. Swartz, 2005, Elective cholecystectomy after Roux-en-Y gastric bypass: why should asymptomatic gallstones be treated differently in morbidly obese patients?, Surg Obes Relat Dis, 1, 555, 10.1016/j.soard.2005.08.002 · DOI · Paper page
  160. Tarantino, 2011, Is routine cholecystectomy justified in severely obese patients undergoing a laparoscopic Roux-en-Y gastric bypass procedure? A comparative cohort study, Obes Surg, 21, 1870, 10.1007/s11695-011-0495-x · DOI
  161. Patel, 2006, Gallbladder management during laparoscopic Roux-en-Y gastric bypass surgery: routine preoperative screening for gallstones and postoperative prophylactic medical treatment are not necessary, Am Surg, 72, 857, 10.1177/000313480607201003 · DOI
  162. Ellner, 2007, Routine cholecystectomy is not mandatory during morbid obesity surgery, Surg Obes Relat Dis, 3, 456, 10.1016/j.soard.2006.11.008 · DOI · Paper page
  163. Portenier, 2007, Expectant management of the asymptomatic gallbladder at Roux-en-Y gastric bypass, Surg Obes Relat Dis, 3, 476, 10.1016/j.soard.2007.02.006 · DOI
  164. Shiffman, 1993, Gallstones in patients with morbid obesity. Relationship to body weight, weight loss and gallbladder bile cholesterol solubility, Int J Obes Relat Metab Disord, 17, 153
  165. Fakhry, 1987, Cholecystectomy in morbidly obese patients, Am Surg, 53, 26
  166. Plecka Ostlund, 2012, Population-based study of the need for cholecystectomy after obesity surgery, Br J Surg, 99, 864, 10.1002/bjs.8701 · DOI
  167. Worni, 2012, Cholecystectomy concomitant with laparoscopic gastric bypass: a trend analysis of the nationwide inpatient sample from 2001 to 2008, Obes Surg, 22, 220, 10.1007/s11695-011-0575-y · DOI · Paper page
  168. Escalona, 2008, Routine preoperative ultrasonography and selective cholecystectomy in laparoscopic Roux-en-Y gastric bypass. Why not?, Obes Surg, 18, 47, 10.1007/s11695-007-9262-4 · DOI
  169. Fobi, 1998, Access to the bypassed stomach after gastric bypass, Obes Surg, 8, 289, 10.1381/096089298765554494 · DOI
  170. Benarroch-Gampel, 2012, Cost-effectiveness analysis of cholecystectomy during Roux-en-Y gastric bypass for morbid obesity, Surgery, 152, 363, 10.1016/j.surg.2012.06.013 · DOI
  171. van Liessum, 1989, Postprandial gallbladder motility during long term treatment with the long-acting somatostatin analog SMS 201–995 in acromegaly, J Clin Endocrinol Metab, 69, 557, 10.1210/jcem-69-3-557 · DOI
  172. Avila, 1998, Sonography of gallbladder abnormalities in acromegaly patients following octreotide and ursodiol therapy: incidence and time course, J Clin Ultrasound, 26, 289, 10.1002/(SICI)1097-0096(199807/08)26:6<289::AID-JCU2>3.0.CO;2-E · DOI
  173. Montini, 1994, Cholelithiasis and acromegaly: therapeutic strategies, Clin Endocrinol, 40, 401, 10.1111/j.1365-2265.1994.tb03938.x · DOI
  174. Roti, 1990, Chronic treatment with a long-acting somatostatin analogue in a patient with intestinal carcinoid tumor: occurrence of cholelithiasis, J Endocrinol Invest, 13, 69, 10.1007/BF03348589 · DOI
  175. Attanasio, 2008, Somatostatin analogs and gallstones: a retrospective survey on a large series of acromegalic patients, J Endocrinol Invest, 31, 704, 10.1007/BF03346419 · DOI
  176. Venneman, 2006, Gallstone disease: primary and secondary prevention, Best Pract Res Clin Gastroenterol, 20, 1063, 10.1016/j.bpg.2006.03.008 · DOI
  177. Maringhini, 1993, Biliary sludge and gallstones in pregnancy: incidence, risk factors, and natural history, Ann Intern Med, 119, 116, 10.7326/0003-4819-119-2-199307150-00004 · DOI
  178. Sitzmann, 1990, Cholecystokinin prevents parenteral nutrition induced biliary sludge in humans, Surg Gynecol Obstet, 170, 25
  179. Zoli, 1993, Promotion of gallbladder emptying by intravenous aminoacids, Lancet, 341, 1240, 10.1016/0140-6736(93)91146-D · DOI
  180. Quigley, 1993, Hepatobiliary complications of total parenteral nutrition, Gastroenterology, 104, 286, 10.1016/0016-5085(93)90864-9 · DOI
  181. Marks, 1994, Natural history and treatment with ursodiol of gallstones formed during rapid loss of weight in man, Dig Dis Sci, 39, 1981, 10.1007/BF02088135 · DOI
  182. Valdivieso, 1993, Pregnancy and cholelithiasis: pathogenesis and natural course of gallstones diagnosed in early puerperium, Hepatology, 17, 1
  183. Doty, 1985, Cholecystokinin prophylaxis of parenteral nutrition-induced gallbladder disease, Ann Surg, 201, 76
  184. Dawes, 1997, Cholecystokinin increases bile acid synthesis with total parenteral nutrition but does not prevent stone formation, J Surg Res, 67, 84, 10.1006/jsre.1996.4953 · DOI
  185. Wu, 2000, Rapid intravenous administration of amino acids prevents biliary sludge induced by total parenteral nutrition in humans, J Hepatobiliary Pancreat Surg, 7, 504, 10.1007/s005340070022 · DOI
  186. Diamanti, 2013, Disappearance of the gallstones under SMOFlipid: true or coincidental association?, Clin Nutr, 32, 150, 10.1016/j.clnu.2012.11.002 · DOI
  187. Berr, 1992, Dietary N-3 polyunsaturated fatty acids decrease biliary cholesterol saturation in gallstone disease, Hepatology, 16, 960, 10.1002/hep.1840160418 · DOI · Paper page
  188. Kim, 2012, N-3 polyunsaturated fatty acid attenuates cholesterol gallstones by suppressing mucin production with a high cholesterol diet in mice, J Gastroenterol Hepatol, 27, 1745, 10.1111/j.1440-1746.2012.07227.x · DOI
  189. Marjoribanks, 2012, Long term hormone therapy for perimenopausal and postmenopausal women, Cochrane Database Syst Rev, 7, CD004143
  190. Cirillo, 2005, Effect of estrogen therapy on gallbladder disease, JAMA, 293, 330, 10.1001/jama.293.3.330 · DOI
  191. Simon, 2001, Effect of estrogen plus progestin on risk for biliary tract surgery in postmenopausal women with coronary artery disease. The Heart and Estrogen/progestin Replacement Study, Ann Intern Med, 135, 493, 10.7326/0003-4819-135-7-200110020-00008 · DOI
  192. Kratzer, 1998, Difficult bile duct stone recurrence after endoscopy and extracorporeal shockwave lithotripsy, Hepatogastroenterology, 45, 910
  193. Testoni, 1991, Long-term efficacy of endoscopic papillo-sphincterotomy for common bile duct stones and benign papillary stenosis, Surg Endosc, 5, 135, 10.1007/BF02653220 · DOI
  194. Tanaka, 1998, Long-term consequence of endoscopic sphincterotomy for bile duct stones, Gastrointest Endosc, 48, 465, 10.1016/S0016-5107(98)70086-0 · DOI
  195. Sugiyama, 2004, Pancreatic juice can reflux into the bile duct in patients without anomalous pancreaticobiliary junction, J Gastroenterol, 39, 1021, 10.1007/s00535-004-1457-z · DOI
  196. Bergman, 1996, Long-term follow-up after endoscopic sphincterotomy for bile duct stones in patients younger than 60 years of age, Gastrointest Endosc, 44, 643, 10.1016/S0016-5107(96)70045-7 · DOI
  197. Duh, 1997, Accessory hepatic duct associated with a choledochal cyst, Pediatr Surg Int, 12, 54, 10.1007/BF01194803 · DOI
  198. Caddy, 2006, Gallstone disease: symptoms, diagnosis and endoscopic management of common bile duct stones, Best Pract Res Clin Gastroenterol, 20, 1085, 10.1016/j.bpg.2006.03.002 · DOI
  199. Katsinelos, 2008, Combination of endoprostheses and oral ursodeoxycholic acid or placebo in the treatment of difficult to extract common bile duct stones, Dig Liver Dis, 40, 453, 10.1016/j.dld.2007.11.012 · DOI
  200. Rosmorduc, 2001, MDR3 gene defect in adults with symptomatic intrahepatic and gallbladder cholesterol cholelithiasis, Gastroenterology, 120, 1459, 10.1053/gast.2001.23947 · DOI

200 of 647 shown

Cited by

Sorted by citations

See all 576

Metadata

Venue
Journal of Hepatology
Publisher
Elsevier BV
Published
2016-07
Volume
65
Issue
1
Pages
146-181
ISSN
0168-8278
DOI
10.1016/j.jhep.2016.03.005
Cited by
576
References
15
Language
en
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review